DUBLIN and RALEIGH, N.C., Feb. 23, 2015 -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (ENDP) (ENL.TO), and BioDelivery Sciences International, Inc. (BDSI) announced today that ...
DUBLIN, Feb. 22, 2016 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), today announced the availability of BELBUCA™ (buprenorphine) buccal ...
Endo Pharmaceuticals and BioDelivery Sciences announced that the Food and Drug Administration (FDA) has accepted for review its New Drug Application (NDA) for Belbuca (buprenorphine HCl) buccal film ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results